Skip to main content
Top
Published in: Modern Rheumatology 1/2006

01-02-2006 | ORIGINAL ARTICLE

Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis

Authors: Yasumori Izumi, Masahiro Tominaga, Nozomi Iwanaga, Mingguo Huang, Fumiko Tanaka, Kouichiro Aratake, Kazuhiko Arima, Mami Tamai, Makoto Kamachi, Hideki Nakamura, Hiroaki Ida, Tomoki Origuchi, Atsushi Kawakami, Katsumi Eguchi

Published in: Modern Rheumatology | Issue 1/2006

Login to get access
Metadata
Title
Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis
Authors
Yasumori Izumi
Masahiro Tominaga
Nozomi Iwanaga
Mingguo Huang
Fumiko Tanaka
Kouichiro Aratake
Kazuhiko Arima
Mami Tamai
Makoto Kamachi
Hideki Nakamura
Hiroaki Ida
Tomoki Origuchi
Atsushi Kawakami
Katsumi Eguchi
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Modern Rheumatology / Issue 1/2006
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-005-0448-0

Other articles of this Issue 1/2006

Modern Rheumatology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine